|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/51 | |
| A61K 31/404 | |||
| A61K 31/506 | |||
| B82Y 5/00 |
| (11) | Number of the document | 3104838 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15707019.4 |
| Date of filing the European patent application | 2015-02-13 | |
| (97) | Date of publication of the European application | 2016-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/015887 |
| Date | 2015-02-13 |
| (87) | Number | WO 2015/123562 |
| Date | 2015-08-20 |
| (30) | Number | Date | Country code |
| 201461939363 P | 2014-02-13 | US |
| (72) |
FIGUEIREDO, Maria, US
PEEKE, Erick, US
DEWITT, David, US
VAN GEEN HOVEN, Christina, US
TROIANO, Greg, US
WRIGHT, James, US
SONG, Young-ho, US
WANG, Hong, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017-5755,
US
|
| (54) | THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME |
| THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME |